Health Dictionary Find a Doctor

Duodenal atresia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

For patient information, click here

Synonyms and keywords: Atresia of duodenum, atresia duodenum, duodenal stenosis.

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

Duodenal atresia is the congenital absence or complete closure of a portion of the lumen of the duodenum. Intestinal atresia, including duodenal atresia, may be classified into four subtypes: Type I, Type II, Type III, and Type IV. Type I is the most common subtype which involves the complete mucosal membrane, with muscularis and serosa remaining intact. The prevalance of duodenal atresia is 0.1 to 0.4 per 100000. It commonly affects neonates and has a male to female ratio of 2 to 1. The symptoms of duodenal atresia usually develop in the first 48 hours of life, and start with symptoms such as bilious vomiting in 80% of the cases. Prognosis is generally very good, and the survival rate of patients with duodenal atresia is approximately 90%.

Historical Perspective

In 1900, J. Tandler reported duodenal stenosis due to failure of recanalization of duodenum during fetal development in pregnancy. In 1961, Thomas Santulli and William Blanc described the figure 8 formation of small bowel, which is described as apple-peel intestinal atresia. In 1936, William Ladd developed a surgical procedure to correct the duodenal malrotation.

Classification

Intestinal atresia, including duodenal atresia, may be classified into four subtypes: Type I, Type II, Type III, and Type IV. Type I is the most common subtype which involves the complete mucosal membrane, with muscularis and serosa remaining intact.

Pathophysiology

It is thought that duodenal atresia is the result of failure of neural cell migration during the 8th to 10th week of duodenal re-canalization. It is associated with down syndrome, vertebral defects, anal anomalies, esophageal atresia, annular pancreas, malrotation, renal abnormalities, cardiac causes, and mandibulofacial anomalies.

Causes

The cause of duodenal atresia has not been identified.

Differentiating duodenal atresia from Other Diseases

Duodenal atresia must be differentiated from other diseases that cause persistent vomiting, and feeding difficulties, such as volvulus, jejuno-ileal atresia, malrotation, and meconium ileus. It is differentiated based on imaging.

Epidemiology and Demographics

The prevalance of duodenal atresia is 0.1 to 0.4 per 100000. It commonly affects neonates and has a male to female ratio of 2 to 1.

Risk Factors

The most potent risk factor in the development of duodenal atresia is down syndrome. Other risk factors include annular pancreas, and VACTERL syndrome.

Screening

There is insufficient evidence to recommend routine screening for duodenal atresia. However, screening for down syndrome may show duodenal atresia during pregnancy.

Natural History, Complications, and Prognosis

The symptoms of duodenal atresia usually develop in the first 48 hours of life, and start with symptoms such as bilious vomiting in 80% of the cases. Prognosis is generally very good, and the survival rate of patients with duodenal atresia is approximately 90%.

Diagnosis

Diagnostic Criteria

Duodenal atresia does not have a diagnostic study of choice. However, abdominal x-ray and ultrasound can confirm duodenal atresia.

History and Symptoms

The hallmark of duodenal atresia is bilious emesis with in the first 48 hours of life. A positive history of persistent emesis and feeding difficulties is suggestive of duodenal atresia. The most common symptoms of duodenal atresia include bilious emesis, persistent emesis, and feeding difficulties.

Physical Examination

Common physical examination findings of duodenal atresia include abdominal distension, dehydration, and restlessness.

Laboratory Findings

Laboratory findings consistent with the diagnosis of duodenal atresia include polyhydramnios on prenatal ultrasound, hypokalemia, and hyperchloremia.

Electrocardiogram

There are no ECG findings associated with duodenal atresia.

X-ray

An abdominal x-ray may be helpful in the diagnosis of duodenal atresia. Findings on the abdominal x-ray diagnostic of duodenal atresia include double bubble sign which is indicative of gas present in the stomach and absent in the distal small intestine.

Ultrasound

Ultrasound may be helpful in the diagnosis of duodenal atresia. Findings on ultrasound suggestive of duodenal atresia include polyhydramnios in pregnancy, and air fluid levels in the stomach with absent gas in the distal colon. Echocardiography can be performed to check for cardiac defect in infants with associated down syndrome.

CT scan

The CT scan findings associated with duodenal atresia are similar to the abdominal x-ray and ultrasound findings.

MRI

The MRI findings associated with duodenal atresia are similar to the abdominal x-ray and ultrasound findings.

Other Imaging Findings

Barium swallow study can be performed post operatively in duodenal atresia to make sure there is no leak in the anastomosis.

Other Diagnostic Studies

There are no other diagnostic studies associated with duodenal atresia.

Treatment

Medical Therapy

There is no medical treatment for duodenal atresia. Medical management to consider in duodenal atresia in preparation for surgery are orogastric decompression of the stomach, fluid resuscitation, broad-spectrum antibiotics, and vitamin K.

Surgery

Surgery is the mainstay of treatment for duodenal atresia. A nasogastric or orogastric tube should be inserted to decompress the abdomen. A laparotomy or laparoscopy can be performed to correct duodenal atresia. Surgical procedures include duodenoduodenostomy, and duodenojejunostomy.

Primary Prevention

There are no established measures for the primary prevention of duodenal atresia.

Secondary Prevention

Effective measures for the secondary prevention of duodenal atresia include prenatal ultrasound, postnatal abdominal x-ray and ultrasound, and surgical repair.

Template:WH Template:WS


Template:WikiDoc Sources

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

In 1900, J. Tandler reported duodenal stenosis due to failure of recanalization of duodenum during fetal development in pregnancy. In 1961, Thomas Santulli and William Blanc described the figure 8 formation of small bowel, which is described as apple-peel intestinal atresia. In 1936, William Ladd developed a surgical procedure to correct the duodenal malrotation.

Historical Perspective

Discovery

Duodenal atresia discovery is as follows:[1][2]

  • In 1900, J. Tandler was the first to discover the association of duodenal stenosis due to failure of recanalization of the embryonic duodenum and the development of duodenal atresia.
  • In 1961, Thomas V. Santulli and William A. Blanc described apple-peel intestinal atresia, which is the figure 8 formation of the small bowel.

Landmark Events in the Development of Treatment Strategies

  • In 1936, a surgical procedure was developed by William Ladd to to correct the malrotation of duodenal atresia.[3]

References

  1. Tandler J. Zur entwicklungsdes chichte des menschlichen duodenum in fruhen embry-onalstedien. Morphol Jahrb 1900; 29: 187
  2. SANTULLI TV, BLANC WA (1961). “Congenital atresia of the intestine: pathogenesis and treatment”. Ann Surg. 154: 939–48. PMC 1465932. PMID 14497096.
  3. Morris, Grant; Kennedy, Alfred; Cochran, William (2016). “Small Bowel Congenital Anomalies: a Review and Update”. Current Gastroenterology Reports. 18 (4). doi:10.1007/s11894-016-0490-4. ISSN 1522-8037.

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

Intestinal atresia, including duodenal atresia, may be classified into four subtypes: Type I, Type II, Type III, and Type IV. Type I is the most common subtype which involves the complete mucosal membrane, with muscularis and serosa remaining intact.

Classification

 
 
 
 
 
 
 
 
Intestinal atresia according
to the origin of the abnormality
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Duodenum
 
 
 
 
Jejunum
 
 
 
 
Ileum
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
•Type I
•Type II
•Type III
•Type IV
 
 
 
 
 
 
 

References

  1. Morris, Grant; Kennedy, Alfred; Cochran, William (2016). “Small Bowel Congenital Anomalies: a Review and Update”. Current Gastroenterology Reports. 18 (4). doi:10.1007/s11894-016-0490-4. ISSN 1522-8037.
  2. Kao KJ, Fleischer R, Bradford WD, Woodard BH (1983). “Multiple congenital septal atresias of the intestine: histomorphologic and pathogenetic implications”. Pediatr Pathol. 1 (4): 443–8. PMID 6687294.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

It is thought that duodenal atresia is the result of failure of neural cell migration during the 8th to 10th week of duodenal re-canalization. It is associated with down syndrome, vertebral defects, anal anomalies, esophageal atresia, annular pancreas, malrotation, renal abnormalities, cardiac causes, and mandibulofacial anomalies.

Pathophysiology

Pathogenesis

  • Duodenum starts developing during the 6th and 7th week of gestation.[1][2]
    • Re-canalization occurs during the 8th to 10th week of gestation.
  • It is thought that duodenal atresia is the result of failure of re-canalization of the duodenum in 8 to 10 weeks of fetal development.
    • This is due to failure of neural cell migration
Duodenum Anatomy.Source: Libre Pathology


Genetics

Associated Conditions

Duodenal atresia is commonly associated with the following:[3][4]

References

  1. Ando H, Kaneko K, Ito F, Seo T, Harada T, Watanabe Y (1999). “Embryogenesis of pancreaticobiliary maljunction inferred from development of duodenal atresia”. J Hepatobiliary Pancreat Surg. 6 (1): 50–4. PMID 10436237.
  2. Boyden EA, Cope JG, Bill AH (1967). “Anatomy and embryology of congenital intrinsic obstruction of the duodenum”. Am J Surg. 114 (2): 190–202. PMID 6028984.
  3. Freeman, SB; Torfs, CP; Romitti, PA; Royle, MH; Druschel, C; Hobbs, CA; Sherman, SL (2009). “Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects”. Clinical Genetics. 75 (2): 180–184. doi:10.1111/j.1399-0004.2008.01110.x. ISSN 0009-9163.
  4. Morris, Grant; Kennedy, Alfred; Cochran, William (2016). “Small Bowel Congenital Anomalies: a Review and Update”. Current Gastroenterology Reports. 18 (4). doi:10.1007/s11894-016-0490-4. ISSN 1522-8037.

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

The cause of duodenal atresia has not been identified. To review risk factors for the development of duodenal atresia, click here.

Causes

Life-threatening Causes

  • There are no life-threatening causes of duodenal atresia, however complications resulting from untreated duodenal atresia is common.

Genetic Causes

  • There are no known genetic causes of duodenal atresia.

Causes by Organ System

Cardiovascular No underlying causes
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect No underlying causes
Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental No underlying causes
Gastroenterologic No underlying causes
Genetic No underlying causes
Hematologic No underlying causes
Iatrogenic No underlying causes
Infectious Disease No underlying causes
Musculoskeletal/Orthopedic No underlying causes
Neurologic No underlying causes
Nutritional/Metabolic No underlying causes
Obstetric/Gynecologic No underlying causes
Oncologic No underlying causes
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte No underlying causes
Rheumatology/Immunology/Allergy No underlying causes
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous No underlying causes

References

Template:WH Template:WS

Differentiating Duodenal atresia from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

Duodenal atresia must be differentiated from other diseases that cause persistent vomiting, and feeding difficulties, such as volvulus, jejuno-ileal atresia, malrotation, and meconium ileus. It is differentiated based on imaging.

Differentiating duodenal atresia from other Diseases

  • Duodenal atresia must be differentiated from other diseases that cause persistent vomiting, and feeding difficulties, such as volvulus, jejuno-ileal atresia, and malrotation.[1][2][3]
Diseases History and Symptoms Physical Examination Laboratory Findings Other Findings
Vomiting Feeding difficulty Stool present Bilious vomitus Abdominal distension Abdominal tenderness Dehydrated Abdominal ultrasound Abdominal x-ray Electrolytes
Duodenal Atresia + + +/- + +/- + + Gas in stomach with absent gas in small intestine Stomach distension and air fluid levels

Double bubble sign

Hypokalemia

Hyperchloremia

Down syndrome
Jejuno-ileal atresia + + +/- + + + + Gas in stomach with no gas in colon Stomach and proximal small intestine distension Hypokalemia

Hyperchloremia

Volvulus + + +/- + + + + Spiral sign Malrotation of intestine with gas in stomach and air fluid levels Hypokalemia

Hyperchloremia

Meconium ileus + + +/- + + + + Distension Air fluid levels Hypokalemia

Hyperchloremia

Cystic fibrosis

References

  1. Adams, Stephen D.; Stanton, Michael P. (2014). “Malrotation and intestinal atresias”. Early Human Development. 90 (12): 921–925. doi:10.1016/j.earlhumdev.2014.09.017. ISSN 0378-3782.
  2. Morris, Grant; Kennedy, Alfred; Cochran, William (2016). “Small Bowel Congenital Anomalies: a Review and Update”. Current Gastroenterology Reports. 18 (4). doi:10.1007/s11894-016-0490-4. ISSN 1522-8037.
  3. Kimura K, Loening-Baucke V (2000). “Bilious vomiting in the newborn: rapid diagnosis of intestinal obstruction”. Am Fam Physician. 61 (9): 2791–8. PMID 10821158.

Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

The prevalance of duodenal atresia is 0.1 to 0.4 per 100000. It commonly affects neonates and has a male to female ratio of 2 to 1.

Epidemiology and Demographics

The epidemiology and demographics of duodenal atresia are as follows:[1][2]

Incidence

Prevalence

Age

  • Duodenal atresia commonly affects individuals in infancy.

Race

  • There is no racial predilection to duodenal atresia.

Gender

References

  1. Best, Kate E; Tennant, Peter W G; Addor, Marie-Claude; Bianchi, Fabrizio; Boyd, Patricia; Calzolari, Elisa; Dias, Carlos Matias; Doray, Berenice; Draper, Elizabeth; Garne, Ester; Gatt, Miriam; Greenlees, Ruth; Haeusler, Martin; Khoshnood, Babak; McDonnell, Bob; Mullaney, Carmel; Nelen, Vera; Randrianaivo, Hanitra; Rissmann, Anke; Salvador, Joaquin; Tucker, David; Wellesly, Diana; Rankin, Judith (2012). “Epidemiology of small intestinal atresia in Europe: a register-based study”. Archives of Disease in Childhood – Fetal and Neonatal Edition. 97 (5): F353–F358. doi:10.1136/fetalneonatal-2011-300631. ISSN 1359-2998.
  2. Morris, Grant; Kennedy, Alfred; Cochran, William (2016). “Small Bowel Congenital Anomalies: a Review and Update”. Current Gastroenterology Reports. 18 (4). doi:10.1007/s11894-016-0490-4. ISSN 1522-8037.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

The most potent risk factor in the development of duodenal atresia is down syndrome. Other risk factors include annular pancreas, and VACTERL syndrome.

Risk Factors

The risk factors are as follows:[1][2][3]

  • The most potent risk factor in the development of duodenal atresia is down syndrome.

Common Risk Factors

  • Common risk factors in the development of duodenal atresia include:

Less Common Risk Factors

References

  1. Freeman, SB; Torfs, CP; Romitti, PA; Royle, MH; Druschel, C; Hobbs, CA; Sherman, SL (2009). “Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects”. Clinical Genetics. 75 (2): 180–184. doi:10.1111/j.1399-0004.2008.01110.x. ISSN 0009-9163.
  2. Morris, Grant; Kennedy, Alfred; Cochran, William (2016). “Small Bowel Congenital Anomalies: a Review and Update”. Current Gastroenterology Reports. 18 (4). doi:10.1007/s11894-016-0490-4. ISSN 1522-8037.
  3. Adams, Stephen D.; Stanton, Michael P. (2014). “Malrotation and intestinal atresias”. Early Human Development. 90 (12): 921–925. doi:10.1016/j.earlhumdev.2014.09.017. ISSN 0378-3782.

Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

There is insufficient evidence to recommend routine screening for duodenal atresia. However, screening for down syndrome may show duodenal atresia during pregnancy.

Screening

  • There is insufficient evidence to recommend routine screening for duodenal atresia.

Down Syndrome Screening

Screening for down syndrome is as follows:[1][2][3][4][5][6]

  • Genetic counseling is usually offered to families who may have an increased chance of having a child with Down syndrome along with:
    • genetic testing
    • amniocentesis
      • Involves inserting instruments into the uterus which carry a small risk of causing fetal injury.
    • chorionic villus sampling (CVS)
      • Involves inserting instruments into the uterus which carry a small risk of causing fetal injury.
    • Percutaneous umbilical blood sampling (PUBS) are usually offered
  • Common screening procedures for Down syndrome are given in Table 1.
Table 1: Common first and second trimester Down syndrome screens
Screen When performed (weeks gestation) Detection rate False positive rate Description
Triple screen 15–20 75% 8.5% This test measures the maternal serum alpha feto protein (a fetal liver protein), estriol (a pregnancy hormone), and human chorionic gonadotropin (hCG, a pregnancy hormone).[7]
Quad screen 15–20 79% 7.5% This test measures the maternal serum alpha feto protein (a fetal liver protein), estriol (a pregnancy hormone), human chorionic gonadotropin (hCG, a pregnancy hormone), and high inhibin-Alpha (INHA).[7]
AFP/free beta screen 13–22 80% 2.8% This test measures the alpha feto protein, produced by the fetus, and free beta hCG, produced by the placenta.
Nuchal translucency/free beta/PAPPA screen 10–13.5 91%[8] 5%[8] Uses ultrasound to measure Nuchal Translucency in addition to the freeBeta hCG and PAPPA (pregnancy-associated plasma protein A). NIH has confirmed that this first trimester test is more accurate than second trimester screening methods.[9]
Ultrasound of fetus with Down syndrome and megacystis

References

  1. Eddleman, Keith A.; et al. (2006). “Pregnancy loss rates after midtrimester amniocentesis”. Obstet Gynecol. 108 (5): 1067–1072. Retrieved 2006-12-09. PMID 17077226
  2. Caroline Mansfield, Suellen Hopfer, Theresa M. Marteau (1999). “Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review”. Prenatal Diagnosis. 19 (9): 808–812. PMID 10521836 This is similar to 90% results found by David W. Britt, Samantha T. Risinger, Virginia Miller, Mary K. Mans, Eric L. Krivchenia, Mark I. Evans (1999). “Determinants of parental decisions after the prenatal diagnosis of Down syndrome: Bringing in context”. American Journal of Medical Genetics. 93 (5): 410–416. PMID 10951466
  3. Fackler, A. “Down syndrome”. Retrieved 2006-09-07.
  4. Will, George (2005-04-14). “Eugenics By Abortion: Is perfection an entitlement?”. Washington Post: A37. Retrieved 2006-07-03.
  5. Erik Parens and Adrienne Asch (2003). “Disability rights critique of prenatal genetic testing: Reflections and recommendations”. Mental Retardation and Developmental Disabilities Research Reviews. 9 (1): 40–47. Retrieved 2006-07-03. PMID 12587137
  6. Glover, NM and Glover, SJ (1996). “Ethical and legal issues regarding selective abortion of fetuses with Down syndrome”. Ment. Retard. 34 (4): 207–214. PMID 8828339.
  7. 7.0 7.1 For a current estimate of rates, see Benn, PA, J Ying, T Beazoglou, JFX Egan. “Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustments for cross-identification and double-positive results”. Prenatal Diagnosis. 21 (1): 46–51. PMID 11180240
  8. 8.0 8.1 Some practices report adding Nasal Bone measurements and increasing the detection rate to 95% with a 2% False Positive Rate.
  9. NIH FASTER study (NEJM 2005 (353):2001). See also J.L. Simplson’s editorial (NEJM 2005 (353):19).

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

The symptoms of duodenal atresia usually develop in the first 48 hours of life, and start with symptoms such as bilious vomiting in 80% of the cases. Prognosis is generally very good, and the survival rate of patients with duodenal atresia is approximately 90%.

Natural History, Complications, and Prognosis

Natural History

  • The symptoms of duodenal atresia usually develop in the first 48 hours of life, and start with symptoms such as vomiting.[1]
  • If duodenal atresia is left untreated it will result in death.

Complications

The complications of duodenal atresia are as follows:[2][3]

  • There are no complications associated with duodenal atresia, however post surgical complications may occur.

Prognosis

  • Prognosis is generally good, and the survival rate of patients with duodenal atresia is approximately 90% after surgery.[4]

References

  1. Adams, Stephen D.; Stanton, Michael P. (2014). “Malrotation and intestinal atresias”. Early Human Development. 90 (12): 921–925. doi:10.1016/j.earlhumdev.2014.09.017. ISSN 0378-3782.
  2. Spigland N, Yazbeck S (1990). “Complications associated with surgical treatment of congenital intrinsic duodenal obstruction”. J Pediatr Surg. 25 (11): 1127–30. PMID 2273425.
  3. Kokkonen ML, Kalima T, Jääskeläinen J, Louhimo I (1988). “Duodenal atresia: late follow-up”. J Pediatr Surg. 23 (3): 216–20. PMID 3357136.
  4. Escobar MA, Ladd AP, Grosfeld JL, West KW, Rescorla FJ, Scherer LR; et al. (2004). “Duodenal atresia and stenosis: long-term follow-up over 30 years”. J Pediatr Surg. 39 (6): 867–71, discussion 867-71. PMID 15185215.

Template:WH Template:WS

Diagnosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Electrocardiogram | Laboratory Findings | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Diagnostic Studies | Other Imaging Findings

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Related Chapters

Volvulus, intestinal atresia, malrotation, Bowel obstruction

References

References

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH